4C
DEAD

Serial Number

88232534

Owner

4C Pharma Solutions LLC

Attorney

Timothy X. Gibson

First Use Date

Sep 8, 2018

Filing Date

Dec 17, 2018

Add to watchlist:

No watchlists yet
View on USPTO

4C Trademark

Serial Number: 88232534 • Registration: 5871682

4C is a trademark filed by 4C Pharma Solutions LLC on December 17, 2018. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

4C Pharma Solutions LLC (3 trademarks)

Suite 111
Piscataway, NJ 08854

Entity Type: 16

Trademark Details

Filing Date

December 17, 2018

Registration Date

October 1, 2019

First Use Anywhere

September 8, 2018

First Use in Commerce

September 8, 2018

Published for Opposition

July 16, 2019

Cancellation Date

April 17, 2026

Goods & Services

Providing medical information in the field of pharmacovigilance and clinical trials

Training services in the field of pharmacovigilance and regulatory compliance

Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics

Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to companies to assist them with applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval Interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; business risk assessment services

Technical writing for others; technical writing in the field of medical writing; searching and retrieving information, sites, and other resources available on computer networks for others; consulting services for others in the field of design, planning, and implementation project management of clinical trials and pharmacovigilance; installation and maintenance of pharmacovigilance computer software; tracking and monitoring of safety and/or efficacy for drugs, devices, drug/device combinations, biologics, biosimilars, cosmetics, nutraceuticals or consumer products for others for pharmacovigilance purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 17, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 1, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 1, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2019 NONP
ASSIGNED TO LIE
Jun 13, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
May 30, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 30, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
May 30, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 30, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 30, 2019 ZZZX
WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
May 30, 2019 ISSR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2019 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2019 CNSA
ASSIGNED TO EXAMINER
Mar 13, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 10, 2019 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2019 NWOS
NEW APPLICATION ENTERED
Dec 20, 2018 NWAP